Human Thymidylate Synthase (TYMS) activation kit by CRISPRa
CAT#: GA105028
TYMS CRISPRa kit - CRISPR gene activation of human thymidylate synthetase
CNY 12255.00
CNY 1999.00
CNY 2700.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | TYMS |
Locus ID | 7298 |
Kit Components | GA105028G1, Thymidylate Synthase gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA105028G2, Thymidylate Synthase gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA105028G3, Thymidylate Synthase gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Reference Data | |
RefSeq | NM_001071, NM_001354867, NM_001354868 |
Synonyms | HST422; TMS; TS |
Summary | Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN404814 | TYMS - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |